Cargando…

Modulated Electro-Hyperthermic (mEHT) Treatment in the Therapy of Inoperable Pancreatic Cancer Patients—A Single-Center Case-Control Study

Our present oncological treatment arsenal has limited treatment options for pancreatic ductal adenocarcinoma (PDAC). Extended reviews have shown the benefits of hyperthermia for PDAC, supporting the perspectives with the improvements of the treatment possibilities. METHODS: A retrospective single-ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petenyi, Flora Greta, Garay, Tamas, Muhl, Dorottya, Izso, Blanka, Karaszi, Adam, Borbenyi, Erika, Herold, Magdolna, Herold, Zoltan, Szasz, Attila Marcell, Dank, Magdolna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628793/ https://www.ncbi.nlm.nih.gov/pubmed/34842668 http://dx.doi.org/10.3390/diseases9040081

Ejemplares similares

Review of the Clinical Evidences of Modulated Electro-Hyperthermia (mEHT) Method: An Update for the Practicing Oncologist
por: Szasz, Attila M., et al.
Publicado: (2019)

The Clinical Validation of Modulated Electro-Hyperthermia (mEHT)
por: Lee, Sun-Young, et al.
Publicado: (2023)

Longitudinal Analysis of 1α,25-dihidroxyvitamin D(3) and Homocysteine Changes in Colorectal Cancer
por: Mühl, Dorottya, et al.
Publicado: (2022)

Does Elevated Pre-Treatment Plasma PD-L1 Level Indicate an Increased Tumor Burden and Worse Prognosis in Metastatic Colorectal Cancer?
por: Dank, Magdolna, et al.
Publicado: (2022)

Meta-Analysis of Modulated Electro-Hyperthermia and Tumor Treating Fields in the Treatment of Glioblastomas
por: Szasz, Attila Marcell, et al.
Publicado: (2023)

High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer
por: Barna, Andras Jozsef, et al.
Publicado: (2023)

Evidence based tools to improve efficiency of currently administered oncotherapies for tumors of the hepatopancreatobiliary system
por: Herold, Zoltan, et al.
Publicado: (2021)

Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases
por: Steinhoff, Heinrich, et al.
Publicado: (2023)

Effects of Modulated Electro-Hyperthermia (mEHT) on Two and Three Year Survival of Locally Advanced Cervical Cancer Patients
por: Minnaar, Carrie Anne, et al.
Publicado: (2022)

High plasma CD40 ligand level is associated with more advanced stages and worse prognosis in colorectal cancer
por: Herold, Zoltan, et al.
Publicado: (2022)

Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts
por: Herold, Zoltan, et al.
Publicado: (2022)

Comparison of the effectiveness of integrative immunomodulatory treatments and conventional therapies on the survival of selected gastrointestinal cancer patients
por: Kleef, Ralf, et al.
Publicado: (2023)

The Prediction Analysis of Microarray 50 (PAM50) Gene Expression Classifier Utilized in Indeterminate-Risk Breast Cancer Patients in Hungary: A Consecutive 5-Year Experience
por: Dank, Magdolna, et al.
Publicado: (2023)

Influence of the duration of type 2 diabetes mellitus on colorectal cancer outcomes
por: Herold, Magdolna, et al.
Publicado: (2023)

Deconstructing Immune Cell Infiltration in Human Colorectal Cancer: A Systematic Spatiotemporal Evaluation
por: Ágoston, Emese Irma, et al.
Publicado: (2022)

Personalized Indicator Thrombocytosis Shows Connection to Staging and Indicates Shorter Survival in Colorectal Cancer Patients with or without Type 2 Diabetes
por: Herold, Zoltan, et al.
Publicado: (2020)

Histopathological Chromogranin A-Positivity Is Associated with Right-Sided Colorectal Cancers and Worse Prognosis
por: Herold, Zoltan, et al.
Publicado: (2020)

Does diabetes affect paraneoplastic thrombocytosis in colorectal cancer?
por: Herczeg, Gyorgy, et al.
Publicado: (2022)

Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study
por: Szentmártoni, Gyöngyvér, et al.
Publicado: (2016)

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
por: Acs, Miklos, et al.
Publicado: (2022)

Prognostic and Clinicopathological Correlations of Cell Cycle Marker Expressions before and after the Primary Systemic Therapy of Breast Cancer
por: Tőkés, Tímea, et al.
Publicado: (2019)

Lower serum chromogranin B level is associated with type 1 diabetes and with type 2 diabetes patients with intensive conservative insulin treatment
por: Herold, Zoltan, et al.
Publicado: (2020)

New therapeutic approaches for type 1 diabetes: Disease-modifying therapies
por: Nagy, Geza, et al.
Publicado: (2022)

Serum chromogranin A level continuously rises with the progression of type 1 diabetes, and indicates the presence of both enterochromaffin‐like cell hyperplasia and autoimmune gastritis
por: Herold, Zoltan, et al.
Publicado: (2020)

Thymosin β4 Improves Differentiation and Vascularization of EHTs
por: Ziegler, Tilman, et al.
Publicado: (2017)

Development of LTS and HTS Superconductors for Accelerator Magnets at EAS and EHTS
por: Krauth, H
Publicado: (2005)

Methyl Donors Reduce Cell Proliferation by Diminishing Erk-Signaling and NFkB Levels, While Increasing E-Cadherin Expression in Panc-1 Cell Line
por: Kiss, Eva, et al.
Publicado: (2022)

Correlation between Expression Profiles of Key Signaling Genes in Colorectal Cancer Samples from Type 2 Diabetic and Non-Diabetic Patients
por: Elek, Zsuzsanna, et al.
Publicado: (2020)

Extracorporeal Hyperoxygenation Therapy (EHT) for Carbon Monoxide Poisoning: In-Vitro Proof of Principle
por: Steuer, Niklas B., et al.
Publicado: (2021)

Methyl-Donors Can Induce Apoptosis and Attenuate Both the Akt and the Erk1/2 Mediated Proliferation Pathways in Breast and Lung Cancer Cell Lines
por: Kiss, Eva, et al.
Publicado: (2021)

The Effect of Dietary Methyl-Donor Intake and Other Lifestyle Factors on Cancer Patients in Hungary
por: Kiss, Eva, et al.
Publicado: (2022)

Dynamic FDG-PET/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations
por: Kajáry, Kornélia, et al.
Publicado: (2019)

Demographic Characteristics and Treatment Patterns Among Patients Receiving Palbociclib for HR+/HER2− Advanced Breast Cancer: A Nationwide Real-World Experience
por: Boér, Katalin, et al.
Publicado: (2021)

Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer
por: Lammers, Philip E., et al.
Publicado: (2018)

The role of stigma and depression in the reduced adherence among young breast cancer patients in Hungary
por: Vizin, Gabriella, et al.
Publicado: (2023)

The yeast enzyme Eht1 is an octanoyl-CoA:ethanol acyltransferase that also functions as a thioesterase
por: Knight, Michael J, et al.
Publicado: (2014)

Downregulation of EHT1 and EEB1 in Saccharomyces cerevisiae Alters the Ester Profile of Wine during Fermentation
por: Yang, Xue, et al.
Publicado: (2022)

Zebrafish Models of Rare Hereditary Pediatric Diseases
por: Varga, Máté, et al.
Publicado: (2018)

Inhibition of Female and Male Human Detrusor Smooth Muscle Contraction by the Rac Inhibitors EHT1864 and NSC23766
por: Li, Bingsheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3kfjhln17n4cjrtcsrjl595aen